Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Bullboard Posts
Comment by wasagastaron Mar 03, 2017 3:25pm
104 Views
Post# 25929201

RE:RE:CEO says they will sell...Siemens needs to only pay $14m?

RE:RE:CEO says they will sell...Siemens needs to only pay $14m?
WolfOfTSXStreet wrote: W need some solid purchase orders and figures for the market cap to rise . If they announce a purchase order to health Canada for example or other companies or countries then the market cap will obviously rise. Does a healthcare company come in and swoop this up before that? I wouldn't be surprised if it happens, if it doesn't we just need to be patient. Next week should be interesting, hopefully news comes out this weekend


No we don't need orders yet. Tech is proven and approved and about to sell in Canada, China this quarter. USA next quarter? Look at companies like v.DYA and v.NXO - they are up big on no sales and product that will change things for sure. But this will change the way folks are treated for the heart worldwide and will be widely adopted simply because of the price and efficiency - it will make a difference. DYA market cap $145m, NXO market cap $90m. This should be given the same treatment if not better...
Bullboard Posts